quinazolines has been researched along with Burkitt Lymphoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiaraluce, R; d'Erme, M; Fontana, M; Mai, A; Masci, A; Mastromarino, P; Mosca, L; Rotili, D; Tempera, I | 1 |
| Ishikawa, C; Kimura, M; Mori, N; Okano, Y; Senba, M | 1 |
| Bertrand, FE; Green, TD; McCubrey, JA; Spengeman, JD | 1 |
| Diddens, H; Jackson, RC; Niethammer, D | 1 |
| Aherne, GW; Dive, C; Fisher, TC; Gregory, CD; Hartley, JA; Hickman, JA; Jackman, AL; Milner, AE | 1 |
| Lee, YJ; Shacter, E | 2 |
7 other study(ies) available for quinazolines and Burkitt Lymphoma
| Article | Year |
|---|---|
Biological effects of MC2050, a quinazoline-based PARP-1 inhibitor, in human neuroblastoma and EBV-positive Burkitt's lymphoma cells.
Topics: Burkitt Lymphoma; Dose-Response Relationship, Drug; Enzyme Inhibitors; Herpesvirus 4, Human; Humans; Neuroblastoma; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Tumor Cells, Cultured | 2011 |
Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt's and Hodgkin's lymphomas.
Topics: Animals; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Base Sequence; Blotting, Western; Burkitt Lymphoma; Cell Cycle; DNA Primers; Hodgkin Disease; Humans; Immunohistochemistry; Mice; Mice, Inbred NOD; Mice, SCID; Organophosphates; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Activated EGFR promotes the survival of B-lineage acute leukemia in the absence of stromal cells.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; B-Lymphocytes; Bone Marrow; Bone Marrow Cells; Burkitt Lymphoma; Cell Cycle; Cell Line, Tumor; Cell Separation; Cell Survival; Cells, Cultured; Coculture Techniques; ErbB Receptors; Flow Cytometry; Humans; MAP Kinase Kinase Kinases; Phosphatidylinositol 3-Kinases; Quinazolines; Retroviridae; Stromal Cells; Time Factors; Tumor Cells, Cultured; Tyrphostins | 2005 |
Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
Topics: Antineoplastic Agents; Biological Transport; Burkitt Lymphoma; Cell Line; Drug Resistance; Folic Acid; Folic Acid Antagonists; Humans; Kinetics; Leukemia, Lymphoid; Lymphoma; Methotrexate; Osteosarcoma; Pyrimethamine; Quinazolines; Structure-Activity Relationship; T-Lymphocytes; Tetrahydrofolate Dehydrogenase; Trimetrexate | 1983 |
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
Topics: Apoptosis; Burkitt Lymphoma; DNA Damage; DNA, Neoplasm; Drug Resistance; Floxuridine; Folic Acid; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Thymidylate Synthase; Transfection; Tumor Cells, Cultured | 1993 |
Oxidative stress inhibits apoptosis in human lymphoma cells.
Topics: Adenosine Triphosphate; Annexin A5; Apoptosis; Benzamides; Burkitt Lymphoma; Calcimycin; Caspase Inhibitors; Caspases; DNA Fragmentation; Etoposide; Humans; Hydrogen Peroxide; Oligomycins; Oxidative Stress; Protein Binding; Quinazolines; Quinazolinones; Tumor Cells, Cultured | 1999 |
Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo.
Topics: Adenosine Triphosphate; Apoptosis; Benzamides; Burkitt Lymphoma; Caspase 3; Caspases; Coumarins; Enzyme Activation; Humans; Hydrogen Peroxide; Oligopeptides; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Quinazolinones; Recombinant Proteins; Serine Proteinase Inhibitors; Tumor Cells, Cultured | 2000 |